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ABSTRACT: Over the past few years, many studies on the association between celiac disease and inflammatory bowel disease have been re-
ported. The genetic origin of this association has prompted research that searches for a common link for the concomitant manifestation of these 
pathologies. Clinical studies aim not only to demonstrate this relation, but also to establish the epidemiological frequencies among affected 
individuals and their relatives as compared to the general population. The similar clinical symptoms, difficulties, diagnoses, and therapeutics 
are still a challenge, since this association is unknown to most coloproctologists, thereby culminating in treatments and surgical procedures 
with no benefits for the patient. 
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RESUMO: Nos últimos anos, muitos estudos foram relatados sobre a associação entre a doença celíaca e as doenças inflamatórias intestinais. 
A origem genética dessa associação desperta pesquisas que buscam o elo comum para a manifestação concomitante das patologias. Estudos 
clínicos visam não apenas demonstrar essa relação mas também estabelecer as frequências epidemiológicas entre os indivíduos acometidos e 
seus familiares em relação à população geral. À semelhança do quadro clínico, as dificuldades diagnósticas e terapêuticas são ainda desafios, 
já que tal associação ainda é desconhecida para a maioria dos coloproctologistas, podendo resultar em tratamentos e cirurgias sem benefícios 
ao paciente.
Palavras-chave: doença celíaca; doença de Crohn; proctocolite; associação.
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INTRODUCTION
The celiac disease (CD) is characterized as an 
autoimmune disease caused by the permanent gluten 
intolerance in genetically susceptible individuals1. 
In the past few years, its clinical and ethiopathogen-
ic features have been cleared. Nowadays, it is known 
that in order for it to occur the association of three 
factors is determinant: genetic changes, exposure to 
gluten and altered immune response3.
Histocompatibility antigens class II, HLA-
DQ2 and HLA-DQ8 present changes in celiac pa-
tients3-5. When these subjects are exposed to gluten, 
their immune response is exaggerated, with increase 
in intraepithelial T lymphocytes – in the proximal 
intestine mucosa – and inflammatory cytokines, 
leading to the villous atrophy and poor absorption 
of nutrients6. Excluding gluten from the diet usually 
leads to the regression of morphological changes in 
the proximal intestine7. Such changes result in the 
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clinical variants of the disease and its intensity, so 
the onset of early symptoms can occur during child-
hood or adulthood8,9. Thus, CD fits the differential 
diagnosis of other pathologies that present pain and 
abdominal distension, vomit, iron deficiency and 
malnutrition10.
In adult subjects, the diagnosis of CD should 
include detailed anamnesis, serological and histo-
pathological studies11. However, in this age group 
the disease can be subclinical, and diagnosis can be 
late – sometimes, after surgical approaches, since it 
seems like a picture of acute abdomen, or after other 
therapies that provided no benefits to the patient12,13. 
The immunological characteristics of CD establish a 
relation with other autoimmune conditions, such as 
dermatitis herpetiformis, thyroid diseases, Addison’s 
disease, autoimmune thrombocytopenia, sarcoidosis, 
IgA nephropathy and selective IgA deficiency14-16. 
Approximately 2 to 4% of the insulin dependent pa-
tients with diabetes mellitus present with CD17.
The relation with other autoimmune diseases 
led to studies on the association between CD and 
inflammatory bowel diseases (IBD) in the past few 
years (proctocolitis and Crohn’s disease)18-21.
Crohn’s disease is more common in the termi-
nal ileum. It presents segmental lesions in the diges-
tive tract, affecting all the layers of the organ wall 
and possibly leading to stenosis or fistula. Procto-
colitis is the IBD more commonly associated with 
other autoimmune diseases, such sclerosing cholan-
gitis, and other vasculitis. Anemia and malnutrition 
are systemic repercussions that are present in most 
patients with the disease. The iron-deficiency ane-
mia, which is refractory in patients with IBD, should 
lead to the suspicion of associated CD22.
Many clinical studies and case reports have 
been described in the past few years to relate CD 
and IBD. The prevalence of IBD in CD has been 
described as five to ten times higher in the general 
population23. Shah et al. described a risk of procto-
colitis five times higher relative in first-degree rela-
tives of patients with CD24. Likewise, Cottone et al. 
described the high incidence of proctocolitis in 600 
first-degree relatives of patients with CD25.
Between January 2002 and December 2004, 
the Italian Group of Inflammatory Bowel Diseases 
performed a multicentric study aiming to establish 
the prevalence of IBD among celiac patients. Out 
of the 1,711 patients, 9 (0.5%) serological and his-
tological results that were compatible with the CD 
diagnosis – 6 patients presented with proctocolitis 
and three with Crohn’s disease, lower prevalence in 
comparison to the general population26. 
In 2007, during 1 year period, Masachs et al. 
followed-up three groups of celiac patients, their 
first-degree relatives and a control group, in order to 
identify the prevalence of IBD in celiac patients and 
their relatives. Three cases of Crohn’s disease were 
reported in 86 celiac patients; four cases of Crohn’s 
disease in first-degree relatives; and one case in the 
control group (809 people); no case of proctocolitis 
was reported, which led to the conclusion that celiac 
patients and their first-degree relatives have higher 
chances of having Crohn’s disease if compared to 
the general population27.
Lopez-Vasquez et al. identified mutations in 
the A MICA gene (major histocompatibility com-
plex class I chain related gene A) expressed in the 
gastrointestinal epithelium of patients with IBD28. 
Changes in the MYOIXB gene, responsible for the 
production of myosins and for the intestinal epithe-
lial integrity, are found in celiac patients29 and these 
mutations can also be found in 40% of the patients 
with IBD30,31.
The presence of binding regions shared by 
these diseases, such as 5q31-33 (IBD5 and CELI-
AC2) and 19p13 (IBD6 and CELIAC4)32,33 has sup-
ported this idea. Recently, the description of poly-
morphisms in the genes IL2, region IL21, in 4q27 
and in the gene IL18RAP, in 2q12, reinforces the 
evidence of association between CD and IBD. Be-
sides, the well established relation between Crohn’s 
disease and the gene IL23R34 has been associated 
to CD in the Finn35 and Spanish36 population. Based 
on these findings, Dema et al.37 studied the genes 
NKX2-3, IRGM and ATG16L1, whose changes are 
clearly defined in the IBDs, in patients with CD and 
first-degree relatives; however, no evidence has been 
established among celiac patients. 
In the service of Hospital das Clínicas de 
Ribeirão Preto (HCRP) at Universidade de São Paulo, 
we had a case of association between CD and Crohn’s 
disease. The patient was 37 years old at the time, and 
in the first appointment she presented with history of 
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pain and abdominal distension, vomit, weight loss 
(10 kg in 3 months) and refractory anemia to treat-
ments prescribed in other medical services. 
There had been an intestinal subocclusion (re-
ferring to enterectomy), however, there were no re-
ports concerning the removed piece. She had the re-
port of an upper digestive endoscopy (UDE) with a 
duodenal biopsy compatible with CD. However, up 
until then she had not been advised to rule out glu-
ten from her diet. We repeated the UDE with new 
biopsies of the second part of the duodenum, and 
the CD diagnosis was confirmed. Admitted to our 
nursery for clinical and nutritional rehabilitation, 
her picture of intestinal occlusion got worse, and 
traffic demonstrated areas of stenosis and dilatation 
of the small intestine (Figure 1). After being sub-
mitted to exploratory laparotomy, segments of the 
jejunum and ileum were shown with stenosis and 
dilatation (Figure 2). The exploration of the surgi-
cal piece demonstrated an inflammatory infiltrate in 
the mesentery, intestinal wall thickening with ulcers 
and fibrin deposition (Figures 3 and 4). The surgi-
cal piece was analyzed twice at the Department of 
Pathological Anatomy at HCRP and the diagnosis 
of Crohn’s disease was confirmed. At the postop-
erative, we initiated nutritional guidance and sus-
pended gluten from the diet. Thirty days after the 
surgery, we started treating the patient for Crohn’s 
disease. An immunomodulator was prescribed and, 
nowadays, the patient had significant clinical im-
provement, without new intercurrences.
Figure 1. Bowel transit showing areas of stenosis and small 
intestine dilatation. 
Figure 2. Stenoses and dilatations.
Figure 3. Inflammatory infiltrate in the mesentery.
Figure 4. Ulcers and fibrin deposition. 
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